SCHACHLE JOSEPH K 4
4 · Ocuphire Pharma, Inc. · Filed Nov 27, 2023
Insider Transaction Report
Form 4
SCHACHLE JOSEPH K
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-11-27+300,000→ 300,000 totalExercise: $2.79Exp: 2033-11-26→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service.